2018
The 2018 launch of ELAJ ACT's operations reflect the firm's intention to use a dynamic business model to meet the requirements of an expanding customer base
2019
The 2019 launch of ELAJ ACT's operations reflect the firm's intention to use a dynamic business model to meet the requirements of an expanding customer base
2020
The 2020 launch of ELAJ ACT's operations reflect the firm's intention to use a dynamic business model to meet the requirements of an expanding customer base
2021
By providing first-rate after-sale services and support, ELAJ ACT has set itself apart from the competition and established a strong reputation in the industry.
2022 - 2023
ELAJ ACT has taken part in both public and private tenders. One of the medical industry's leading firms, ELAJ ACT is a forerunner in the biomedical, clinical laboratory, and pharmaceutical sectors.
